Delivery Order SPE2DB20D9226-SPE2DB22FQ61A

Award Date 7/27/22
Potential Completion Date 8/17/22
Potential Value $32K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,229.60 firm fixed-price delivery order is for the supply of 100-unit vials of the drug Botox. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,306.64 firm fixed-price delivery order covers the supply of 100 unit vials of Botox for the U.S. Department of Defense (DoD) and its medical facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $31,708.50 firm fixed-price delivery order is for the supply of 200 unit vials of BOTOX, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,307.40 firm fixed-price delivery order is for the supply of 100-unit vials of Botox, a branded medication. This award is part of a larger indefinite delivery contract (IDC) with DLA valued up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,508.60 firm fixed-price delivery order is for 200-unit vials of the drug Botox. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,881.10 firm fixed-price delivery order is for the supply of 200-unit vials of Botox. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a comprehensive range of pharmaceutical...
This federal contract award was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,075.52 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to supply 100-unit vials of the drug Botox. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,362.00 firm fixed-price delivery order is for the provision of 200-unit vials of Botox, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,590.50 firm fixed-price delivery order is for the supply of 200-unit vials of Botox, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
This federal contract award was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,307.40, is a firm fixed-price delivery order for the supply of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), under the agency's Medical Supply Chain division. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that...
  • SPE2DB20D9226
    Indefinite Delivery Contract
  • SPE2DB20D9226-SPE2DB22FQ61A
    Delivery Order

This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $31,708.50 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) for the supply of 200-unit vials of the drug Botox.

The award is made under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of various Department of Defense (DoD) healthcare facilities worldwide. This IDC, which runs through December 31, 2025, serves as a prime vendor contract for the direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain. The contract does not have a set-aside designation.

Generated 1/9/25, 9:36 AM